ArticleBritish journal of cancer2019

Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma.

David J Pinato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.